| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.685 | 0.015 | 0.777 | Analgesic | 0.777 0.007 DBMET00836 | DBMET00836 | |
| 0.614 | 0.017 | 0.614 | Aldehyde oxidase inhibitor | 0.209 0.1 DBMET00836 | ||
| 0.529 | 0.008 | 0.529 | Platelet aggregation inhibitor | 0.522 0.008 DBMET00836 | ||
| 0.515 | 0.027 | 0.515 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.42 0.083 DBMET00836 | ||
| 0.489 | 0.012 | 0.489 | Psychostimulant | 0.27 0.051 DBMET00836 | ||
| 0.486 | 0.03 | 0.486 | GABA C receptor rho-3 antagonist | 0.289 0.124 DBMET00836 | ||
| 0.442 | 0.005 | 0.442 | Platelet activating factor antagonist | 0.394 0.005 DBMET00836 | ||
| 0.449 | 0.021 | 0.449 | HERG channel blocker | |||
| 0.459 | 0.034 | 0.459 | 5 Hydroxytryptamine release stimulant | 0.178 0.142 DBMET00836 | ||
| 0.419 | 0.009 | 0.632 | Cholinergic | 0.632 0.004 DBMET00836 | DBMET00836 | |
| 0.425 | 0.018 | 0.425 | Sigma receptor agonist | 0.169 0.074 DBMET00836 | ||
| 0.423 | 0.025 | 0.423 | Cardiotonic | 0.413 0.027 DBMET00836 | ||
| 0.422 | 0.033 | 0.422 | Nootropic | |||
| 0.405 | 0.02 | 0.405 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.393 | 0.016 | 0.393 | 5 Hydroxytryptamine uptake stimulant | 0.243 0.088 DBMET00836 | ||
| 0.385 | 0.011 | 0.486 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.486 0.006 DBMET00836 | DBMET00836 | |
| 0.398 | 0.027 | 0.398 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.36 | 0.014 | 0.36 | Tyrosine 3 hydroxylase inhibitor | 0.279 0.045 DBMET00836 | ||
| 0.341 | 0.004 | 0.496 | Substance P antagonist | 0.496 0.003 DBMET00836 | DBMET00836 | |
| 0.351 | 0.024 | 0.351 | Anesthetic general | 0.135 0.131 DBMET00836 | ||
| 0.364 | 0.049 | 0.364 | Vasodilator, coronary | 0.235 0.149 DBMET00836 | ||
| 0.304 | 0.005 | 0.396 | Acetylcholine agonist | 0.396 0.004 DBMET00836 | DBMET00836 | |
| 0.299 | 0.004 | 0.381 | Acetylcholine muscarinic agonist | 0.381 0.003 DBMET00836 | DBMET00836 | |
| 0.33 | 0.041 | 0.33 | Superoxide dismutase inhibitor | 0.218 0.099 DBMET00836 | ||
| 0.309 | 0.024 | 0.309 | 5 Hydroxytryptamine 1E antagonist | 0.184 0.15 DBMET00836 | ||
| 0.305 | 0.029 | 0.305 | Gastrin inhibitor | |||
| 0.276 | 0.013 | 0.276 | TRKB antagonist | |||
| 0.266 | 0.004 | 0.335 | Neurokinin 1 antagonist | 0.335 0.003 DBMET00836 | DBMET00836 | |
| 0.264 | 0.004 | 0.318 | Neurokinin antagonist | 0.318 0.004 DBMET00836 | DBMET00836 | |
| 0.257 | 0.005 | 0.257 | Platelet growth factor antagonist | 0.084 0.053 DBMET00836 | ||
| 0.31 | 0.066 | 0.31 | Spasmolytic | 0.287 0.075 DBMET00836 | ||
| 0.285 | 0.045 | 0.285 | Anticonvulsant | |||
| 0.256 | 0.016 | 0.256 | Calcium channel blocker | 0.115 0.093 DBMET00836 | ||
| 0.278 | 0.051 | 0.278 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.239 | 0.015 | 0.274 | Antihistaminic | 0.274 0.012 DBMET00836 | DBMET00836 | |
| 0.231 | 0.015 | 0.269 | Histamine antagonist | 0.269 0.012 DBMET00836 | DBMET00836 | |
| 0.218 | 0.004 | 0.288 | Kinesin-like protein 1 inhibitor | 0.288 0.003 DBMET00836 | DBMET00836 | |
| 0.218 | 0.004 | 0.288 | Kinesin antagonist | 0.288 0.003 DBMET00836 | DBMET00836 | |
| 0.218 | 0.005 | 0.218 | Smo receptor antagonist | |||
| 0.259 | 0.05 | 0.259 | MAP kinase kinase 2 inhibitor | |||
| 0.233 | 0.026 | 0.233 | Alpha-N-acetylglucosaminidase inhibitor | 0.139 0.061 DBMET00836 | ||
| 0.205 | 0.005 | 0.298 | Acetylcholine M1 receptor agonist | 0.298 0.004 DBMET00836 | DBMET00836 | |
| 0.218 | 0.019 | 0.246 | Butyrylcholinesterase inhibitor | 0.246 0.015 DBMET00836 | DBMET00836 | |
| 0.226 | 0.031 | 0.226 | 5 Hydroxytryptamine 3E antagonist | 0.185 0.093 DBMET00836 | ||
| 0.254 | 0.064 | 0.254 | Potassium channel blocker | |||
| 0.222 | 0.033 | 0.276 | Acetylcholine M1 receptor antagonist | 0.276 0.019 DBMET00836 | DBMET00836 | |
| 0.209 | 0.022 | 0.296 | Acetylcholine muscarinic antagonist | 0.296 0.009 DBMET00836 | DBMET00836 | |
| 0.289 | 0.102 | 0.289 | Vasodilator, peripheral | |||
| 0.192 | 0.01 | 0.192 | Prolactin inhibitor | 0.098 0.057 DBMET00836 | ||
| 0.185 | 0.004 | 0.185 | Nicotinamide phosphoribosyltransferase inhibitor | 0.066 0.01 DBMET00836 | ||
| 0.209 | 0.032 | 0.209 | Toll-Like receptor 9 antagonist | |||
| 0.246 | 0.069 | 0.246 | DNA synthesis inhibitor | 0.189 0.141 DBMET00836 | ||
| 0.236 | 0.059 | 0.236 | RNA-directed DNA polymerase inhibitor | |||
| 0.237 | 0.065 | 0.237 | Antimitotic | 0.149 0.122 DBMET00836 | ||
| 0.332 | 0.161 | 0.332 | Caspase 9 stimulant | |||
| 0.178 | 0.01 | 0.178 | Acetylcholine nicotinic agonist | 0.078 0.06 DBMET00836 | ||
| 0.223 | 0.056 | 0.223 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.299 | 0.133 | 0.299 | 15-Lipoxygenase inhibitor | |||
| 0.199 | 0.032 | 0.303 | Cholinergic antagonist | 0.303 0.014 DBMET00836 | DBMET00836 | |
| 0.168 | 0.003 | 0.168 | Ryanodine receptor antagonist | 0.098 0.004 DBMET00836 | ||
| 0.188 | 0.025 | 0.188 | Ferrochelatase inhibitor | |||
| 0.21 | 0.05 | 0.21 | Lipocortins synthesis antagonist | |||
| 0.192 | 0.033 | 0.28 | Acetylcholine antagonist | 0.28 0.016 DBMET00836 | DBMET00836 | |
| 0.18 | 0.022 | 0.18 | Calcium channel (voltage-sensitive) blocker | |||
| 0.193 | 0.035 | 0.303 | Acetylcholinesterase inhibitor | 0.303 0.013 DBMET00836 | DBMET00836 | |
| 0.178 | 0.022 | 0.178 | 5 Hydroxytryptamine 3A agonist | |||
| 0.19 | 0.035 | 0.19 | GABA C receptor rho-2 antagonist | |||
| 0.174 | 0.018 | 0.285 | Histamine H1 receptor antagonist | 0.285 0.007 DBMET00836 | DBMET00836 | |
| 0.167 | 0.016 | 0.167 | Ca2+-transporting ATPase inhibitor | 0.136 0.09 DBMET00836 | ||
| 0.191 | 0.041 | 0.191 | Activin receptor-like kinase 2 inhibitor | |||
| 0.172 | 0.026 | 0.172 | Calcium channel N-type blocker | |||
| 0.213 | 0.068 | 0.213 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.149 | 0.005 | 0.149 | Histamine H3 receptor agonist | 0.027 0.019 DBMET00836 | ||
| 0.202 | 0.058 | 0.202 | Peroxidase inhibitor | |||
| 0.167 | 0.024 | 0.167 | Sphingosine 1-phosphate receptor 2 antagonist | 0.12 0.098 DBMET00836 | ||
| 0.233 | 0.092 | 0.233 | Interleukin agonist | |||
| 0.164 | 0.03 | 0.164 | Falcipain 3 inhibitor | |||
| 0.144 | 0.012 | 0.19 | Acetylcholine M2 receptor antagonist | 0.19 0.007 DBMET00836 | DBMET00836 | |
| 0.137 | 0.005 | 0.137 | Histamine agonist | |||
| 0.263 | 0.131 | 0.263 | Calcium channel activator | |||
| 0.171 | 0.041 | 0.171 | Anesthetic local | |||
| 0.238 | 0.111 | 0.238 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.25 | 0.125 | 0.25 | Cholesterol antagonist | |||
| 0.131 | 0.015 | 0.131 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.132 | 0.016 | 0.132 | Phosphodiesterase 6D inhibitor | |||
| 0.12 | 0.005 | 0.12 | Tryptase inhibitor | 0.044 0.018 DBMET00836 | ||
| 0.138 | 0.025 | 0.138 | Acetylcholine release stimulant | |||
| 0.26 | 0.148 | 0.26 | Histamine release inhibitor | |||
| 0.183 | 0.071 | 0.183 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.129 | 0.017 | 0.129 | Glutamate release inhibitor | |||
| 0.177 | 0.067 | 0.177 | Antipruritic | |||
| 0.146 | 0.036 | 0.146 | GABA C receptor agonist | 0.086 0.084 DBMET00836 | ||
| 0.132 | 0.023 | 0.132 | NADH dehydrogenase inhibitor | 0.092 0.054 DBMET00836 | ||
| 0.157 | 0.05 | 0.157 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.131 | 0.029 | 0.131 | Electrolyte absorption antagonist | |||
| 0.111 | 0.009 | 0.111 | Protein kinase C beta inhibitor | |||
| 0.114 | 0.013 | 0.114 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.117 | 0.017 | 0.117 | Calcium channel L-type blocker | |||
| 0.184 | 0.084 | 0.184 | Non-steroidal antiinflammatory agent | |||
| 0.103 | 0.004 | 0.103 | Acetylcholine M4 receptor agonist | |||
| 0.112 | 0.014 | 0.112 | Acetylcholine M5 receptor agonist | |||
| 0.119 | 0.023 | 0.119 | Analgesic, opioid | 0.103 0.029 DBMET00836 | ||
| 0.112 | 0.019 | 0.112 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.105 | 0.014 | 0.105 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.125 | 0.036 | 0.125 | GABA C receptor rho-1 antagonist | |||
| 0.13 | 0.043 | 0.13 | GABA C receptor antagonist | |||
| 0.178 | 0.091 | 0.178 | I kappa B kinase epsilon inhibitor | |||
| 0.157 | 0.07 | 0.157 | Cytidine deaminase inhibitor | |||
| 0.137 | 0.051 | 0.137 | Beta amyloid protein antagonist | |||
| 0.11 | 0.024 | 0.11 | Alpha adrenoreceptor agonist | |||
| 0.134 | 0.049 | 0.182 | 5 Hydroxytryptamine 2B antagonist | 0.182 0.03 DBMET00836 | DBMET00836 | |
| 0.1 | 0.016 | 0.1 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.093 | 0.01 | 0.093 | Purinergic P2Y antagonist | |||
| 0.107 | 0.024 | 0.159 | Acetylcholine M4 receptor antagonist | 0.159 0.009 DBMET00836 | DBMET00836 | |
| 0.112 | 0.031 | 0.112 | Porphobilinogen synthase inhibitor | 0.065 0.061 DBMET00836 | ||
| 0.096 | 0.015 | 0.096 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.088 | 0.007 | 0.088 | CC chemokine receptor 2B antagonist | |||
| 0.122 | 0.042 | 0.122 | Adenylate kinase inhibitor | 0.097 0.073 DBMET00836 | ||
| 0.12 | 0.041 | 0.12 | Creatine kinase inhibitor | |||
| 0.145 | 0.068 | 0.145 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.087 | 0.011 | 0.087 | Oleamide hydrolase inhibitor | |||
| 0.1 | 0.024 | 0.1 | Amidase inhibitor | |||
| 0.11 | 0.034 | 0.11 | Acetylcholine nicotinic antagonist | 0.076 0.06 DBMET00836 | ||
| 0.088 | 0.013 | 0.088 | Phosphodiesterase 1A inhibitor | |||
| 0.079 | 0.005 | 0.079 | Angiotensin AT2 receptor antagonist | 0.053 0.009 DBMET00836 | ||
| 0.104 | 0.029 | 0.104 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.135 | 0.061 | 0.135 | Antibacterial (Helicobacter pylori) | |||
| 0.114 | 0.041 | 0.114 | MAP kinase kinase 1 inhibitor | |||
| 0.095 | 0.021 | 0.095 | Vanilloid 4 agonist | |||
| 0.11 | 0.037 | 0.11 | Histamine N-methyltransferase inhibitor | |||
| 0.082 | 0.01 | 0.082 | Prolactin release inhibitor | 0.062 0.043 DBMET00836 | ||
| 0.091 | 0.02 | 0.091 | 5 Hydroxytryptamine 3 agonist | |||
| 0.137 | 0.066 | 0.137 | Toll-Like receptor antagonist | |||
| 0.114 | 0.046 | 0.114 | Sphingomyelinase inhibitor | |||
| 0.088 | 0.019 | 0.088 | Acyl-CoA dehydrogenase inhibitor | 0.05 0.043 DBMET00836 | ||
| 0.087 | 0.02 | 0.087 | Potassium channel (Tandem pore domain) blocker | |||
| 0.07 | 0.005 | 0.07 | Delayed rectifier potassium channel blocker | |||
| 0.122 | 0.056 | 0.122 | TRPA1 agonist | |||
| 0.095 | 0.031 | 0.095 | Estrogen-related receptor beta agonist | |||
| 0.081 | 0.017 | 0.081 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.094 | 0.03 | 0.094 | Dopamine agonist | |||
| 0.07 | 0.006 | 0.07 | Vascular adhesion protein 1 inhibitor | |||
| 0.218 | 0.155 | 0.218 | Ca(v)3.3 blocker | |||
| 0.085 | 0.022 | 0.085 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.086 | 0.023 | 0.135 | Acetylcholine M3 receptor antagonist | 0.135 0.013 DBMET00836 | DBMET00836 | |
| 0.067 | 0.005 | 0.067 | Purinergic P2Y12 antagonist | |||
| 0.071 | 0.01 | 0.071 | Cholesterol esterase inhibitor | |||
| 0.081 | 0.02 | 0.081 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.052 0.045 DBMET00836 | ||
| 0.104 | 0.043 | 0.104 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.178 | 0.116 | 0.178 | Antiamyloidogenic | |||
| 0.139 | 0.078 | 0.139 | Heat shock protein 70 antagonist | |||
| 0.08 | 0.02 | 0.08 | MDM2 inhibitor | |||
| 0.15 | 0.09 | 0.15 | Tyrosine kinase inhibitor | 0.115 0.113 DBMET00836 | ||
| 0.082 | 0.023 | 0.126 | Acetylcholine M5 receptor antagonist | 0.126 0.011 DBMET00836 | DBMET00836 | |
| 0.094 | 0.038 | 0.094 | Glycine receptor antagonist | |||
| 0.125 | 0.069 | 0.125 | Nav1.3 sodium channel blocker | |||
| 0.264 | 0.208 | 0.264 | 5 Hydroxytryptamine release inhibitor | |||
| 0.06 | 0.004 | 0.06 | Adenosine uptake inhibitor | 0.037 0.018 DBMET00836 | ||
| 0.087 | 0.032 | 0.087 | Phosphodiesterase VI inhibitor | |||
| 0.081 | 0.028 | 0.081 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.07 | 0.017 | 0.07 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.09 | 0.037 | 0.09 | 5 Hydroxytryptamine agonist | |||
| 0.19 | 0.138 | 0.19 | Neuropeptide Y2 antagonist | |||
| 0.123 | 0.071 | 0.123 | Cathepsin H inhibitor | |||
| 0.182 | 0.132 | 0.182 | DNA damaging | |||
| 0.174 | 0.125 | 0.174 | ErbB-1 antagonist | |||
| 0.099 | 0.049 | 0.099 | Alpha 2 adrenoreceptor antagonist | |||
| 0.059 | 0.009 | 0.059 | Phosphodiesterase 6C inhibitor | |||
| 0.09 | 0.041 | 0.09 | Caspase 7 inhibitor | |||
| 0.098 | 0.049 | 0.098 | Calcium antagonist | |||
| 0.092 | 0.044 | 0.092 | Histamine H2 receptor antagonist | |||
| 0.125 | 0.078 | 0.125 | Nav1.2 sodium channel blocker | |||
| 0.058 | 0.012 | 0.058 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.071 | 0.025 | 0.071 | Fatty acid synthase inhibitor | |||
| 0.081 | 0.035 | 0.081 | Neuronal nicotinic receptor antagonist | |||
| 0.103 | 0.058 | 0.103 | UDP-glucose 4-epimerase inhibitor | |||
| 0.074 | 0.029 | 0.074 | Purinergic P2X1 antagonist | |||
| 0.071 | 0.026 | 0.071 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.071 | 0.027 | 0.071 | Calcium channel T-type blocker | |||
| 0.116 | 0.072 | 0.116 | Alkylator | |||
| 0.052 | 0.01 | 0.052 | Calcitonin gene-related peptide antagonist | |||
| 0.109 | 0.067 | 0.109 | Alpha 2b adrenoreceptor antagonist | 0.1 0.074 DBMET00836 | ||
| 0.104 | 0.063 | 0.104 | Alpha 2c adrenoreceptor antagonist | 0.091 0.074 DBMET00836 | ||
| 0.085 | 0.044 | 0.085 | Interferon agonist | |||
| 0.057 | 0.016 | 0.057 | Neuraminidase (Influenza A) inhibitor | |||
| 0.092 | 0.052 | 0.092 | Bromodomain-containing protein 2 inhibitor | |||
| 0.044 | 0.004 | 0.044 | Estrogen-related receptor gamma antagonist | 0.027 0.024 DBMET00836 | ||
| 0.047 | 0.008 | 0.047 | Phosphodiesterase 6B inhibitor | |||
| 0.087 | 0.049 | 0.087 | Adrenaline agonist | |||
| 0.117 | 0.079 | 0.117 | DNA repair enzyme inhibitor | |||
| 0.058 | 0.02 | 0.058 | Histamine H4 receptor antagonist | |||
| 0.106 | 0.07 | 0.211 | GABA receptor agonist | 0.211 0.015 DBMET00836 | DBMET00836 | |
| 0.092 | 0.056 | 0.092 | Phosphodiesterase I inhibitor | |||
| 0.06 | 0.025 | 0.06 | Dipeptidyl peptidase inhibitor | |||
| 0.043 | 0.009 | 0.043 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.038 | 0.004 | 0.038 | Acid ceramidase inhibitor | |||
| 0.13 | 0.096 | 0.13 | Thiol protease inhibitor | |||
| 0.051 | 0.017 | 0.051 | Histamine H1 receptor agonist | |||
| 0.065 | 0.032 | 0.065 | Nicotinic neuronal receptor agonist | |||
| 0.066 | 0.032 | 0.066 | Heat shock protein 90 beta antagonist | |||
| 0.106 | 0.073 | 0.106 | 5 Hydroxytryptamine antagonist | 0.106 0.074 DBMET00836 | ||
| 0.082 | 0.05 | 0.082 | Cell adhesion molecule inhibitor | |||
| 0.102 | 0.07 | 0.143 | 5 Hydroxytryptamine 2 antagonist | 0.143 0.047 DBMET00836 | DBMET00836 | |
| 0.098 | 0.066 | 0.098 | Anabolic | |||
| 0.054 | 0.023 | 0.054 | Dopamine beta hydroxylase inhibitor | |||
| 0.123 | 0.092 | 0.123 | Nav1.6 sodium channel blocker | |||
| 0.04 | 0.009 | 0.04 | Epoxide hydrolase 2 inhibitor | |||
| 0.059 | 0.028 | 0.059 | 5 Hydroxytryptamine 1B agonist | |||
| 0.055 | 0.024 | 0.055 | Histamine H3 receptor antagonist | |||
| 0.06 | 0.029 | 0.06 | Epithelial sodium channel blocker | |||
| 0.077 | 0.047 | 0.077 | Glutamate decarboxylase inhibitor | |||
| 0.065 | 0.035 | 0.065 | Carbonic anhydrase stimulant | |||
| 0.039 | 0.008 | 0.039 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.053 | 0.022 | 0.053 | Toll-Like receptor 2 agonist | |||
| 0.047 | 0.018 | 0.047 | Factor XIIIa inhibitor | |||
| 0.034 | 0.005 | 0.034 | 5 Hydroxytryptamine 4 agonist | 0.027 0.011 DBMET00836 | ||
| 0.052 | 0.023 | 0.052 | Oxytocin agonist | |||
| 0.066 | 0.038 | 0.066 | Calcium channel P-type blocker | |||
| 0.05 | 0.021 | 0.05 | Dipeptidyl peptidase IV inhibitor | |||
| 0.077 | 0.049 | 0.077 | Catalase inhibitor | |||
| 0.043 | 0.017 | 0.043 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.036 0.026 DBMET00836 | ||
| 0.104 | 0.079 | 0.104 | Interleukin 2 antagonist | |||
| 0.109 | 0.084 | 0.109 | Aldehyde dehydrogenase inhibitor | |||
| 0.051 | 0.026 | 0.051 | Adenylate cyclase 1 inhibitor | |||
| 0.049 | 0.025 | 0.049 | CC chemokine 3 receptor antagonist | |||
| 0.082 | 0.058 | 0.082 | CC chemokine 5 receptor agonist | |||
| 0.053 | 0.029 | 0.053 | Squalene epoxidase inhibitor | |||
| 0.031 | 0.007 | 0.031 | Phosphodiesterase 6G inhibitor | |||
| 0.031 | 0.007 | 0.031 | Phosphodiesterase 6H inhibitor | |||
| 0.117 | 0.093 | 0.117 | Interleukin 1 antagonist | |||
| 0.059 | 0.035 | 0.059 | Human rhinovirus A protease inhibitor | |||
| 0.128 | 0.106 | 0.128 | Adenylate cyclase stimulant | |||
| 0.037 | 0.015 | 0.037 | GHS receptor antagonist | |||
| 0.065 | 0.043 | 0.065 | Interferon inducer | |||
| 0.071 | 0.05 | 0.071 | Benzodiazepine agonist | |||
| 0.063 | 0.042 | 0.063 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.036 | 0.015 | 0.036 | Protein kinase C beta II inhibitor | |||
| 0.091 | 0.07 | 0.15 | Platelet activating factor beta antagonist | 0.15 0.038 DBMET00836 | DBMET00836 | |
| 0.144 | 0.124 | 0.144 | Succinate dehydrogenase inhibitor | |||
| 0.028 | 0.008 | 0.028 | Phosphodiesterase 6A inhibitor | |||
| 0.045 | 0.026 | 0.045 | Nerve growth factor antagonist | |||
| 0.036 | 0.017 | 0.036 | CXC chemokine 3 receptor antagonist | |||
| 0.035 | 0.016 | 0.035 | Trypsin II inhibitor | |||
| 0.053 | 0.035 | 0.053 | mTOR inhibitor | |||
| 0.057 | 0.039 | 0.057 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.086 | 0.069 | 0.122 | Polo-like kinase-1 inhibitor | 0.122 0.029 DBMET00836 | DBMET00836 | |
| 0.054 | 0.037 | 0.054 | Alpha-mannosidase inhibitor | |||
| 0.066 | 0.05 | 0.066 | Glutamate (mGluR7) antagonist | |||
| 0.063 | 0.046 | 0.093 | Dopamine D1 antagonist | 0.093 0.027 DBMET00836 | DBMET00836 | |
| 0.074 | 0.057 | 0.074 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.059 | 0.044 | 0.059 | Cyclin D1 inhibitor | |||
| 0.084 | 0.069 | 0.084 | Triose-phosphate isomerase inhibitor | |||
| 0.055 | 0.04 | 0.055 | 5 Hydroxytryptamine 7 agonist | |||
| 0.074 | 0.059 | 0.074 | Fibroblast growth factor 3 antagonist | |||
| 0.061 | 0.047 | 0.061 | Purinergic P2 antagonist | |||
| 0.043 | 0.03 | 0.043 | Dopamine D5 antagonist | 0.036 0.035 DBMET00836 | ||
| 0.061 | 0.048 | 0.061 | Cannabinoid receptor agonist | |||
| 0.021 | 0.008 | 0.021 | Calcitonin gene-related peptide 1 receptor antagonist | |||
| 0.062 | 0.049 | 0.062 | Fibroblast growth factor 2 antagonist | |||
| 0.11 | 0.097 | 0.11 | Tyrosine-protein kinase receptor antagonist | |||
| 0.091 | 0.078 | 0.091 | Nav1.1 sodium channel blocker | |||
| 0.04 | 0.027 | 0.04 | AMPA 4 receptor antagonist | |||
| 0.068 | 0.056 | 0.068 | Aminopeptidase I inhibitor | |||
| 0.068 | 0.057 | 0.068 | Phospholipase D inhibitor | |||
| 0.048 | 0.036 | 0.048 | Cytokine production stimulant | |||
| 0.119 | 0.108 | 0.119 | Aurora-C kinase inhibitor | |||
| 0.046 | 0.034 | 0.046 | CC chemokine 4 receptor antagonist | |||
| 0.134 | 0.124 | 0.134 | DNA methyltransferase I inhibitor | |||
| 0.031 | 0.02 | 0.031 | Purinergic P2Y14 antagonist | |||
| 0.052 | 0.043 | 0.052 | Alcohol oxidase inhibitor | |||
| 0.046 | 0.037 | 0.046 | Benzodiazepine antagonist | |||
| 0.027 | 0.018 | 0.027 | Myristoyl transferase inhibitor | |||
| 0.05 | 0.042 | 0.05 | Cannabinoid CB2 receptor agonist | |||
| 0.138 | 0.129 | 0.138 | DNA methylase inhibitor | |||
| 0.099 | 0.091 | 0.099 | Cell adhesion inhibitor | |||
| 0.077 | 0.069 | 0.077 | Bcr-Abl kinase inhibitor | |||
| 0.014 | 0.007 | 0.014 | Cyclin D2 inhibitor | |||
| 0.123 | 0.116 | 0.123 | Neuropeptide Y1 antagonist | |||
| 0.023 | 0.016 | 0.023 | Dopamine D1 agonist | |||
| 0.067 | 0.061 | 0.067 | Glutamate dehydrogenase inhibitor | |||
| 0.036 | 0.03 | 0.036 | DNA gyrase subunit B inhibitor | |||
| 0.055 | 0.049 | 0.055 | Collagenase 3 inhibitor | |||
| 0.05 | 0.043 | 0.05 | Nicotinic alpha7 receptor agonist | |||
| 0.062 | 0.056 | 0.062 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.025 | 0.019 | 0.025 | 5 Hydroxytryptamine 1F agonist | |||
| 0.021 | 0.015 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.038 | 0.032 | 0.038 | Glutamate (mGluR1a) antagonist | |||
| 0.024 | 0.019 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.018 | 0.013 | 0.018 | Estrogen-related receptor gamma agonist | |||
| 0.071 | 0.066 | 0.092 | 5 Hydroxytryptamine 2A antagonist | 0.092 0.052 DBMET00836 | DBMET00836 | |
| 0.021 | 0.017 | 0.021 | Geranylgeranyltransferase inhibitor | |||
| 0.051 | 0.047 | 0.051 | Glutamate (mGluR1) antagonist | |||
| 0.027 | 0.024 | 0.027 | 5 Hydroxytryptamine 6 agonist | |||
| 0.066 | 0.064 | 0.066 | ErbB-4 antagonist | |||
| 0.071 | 0.08 | 0.205 | Antiadrenergic | 0.205 0.023 DBMET00836 | DBMET00836 | |
| 0.071 | 0.081 | 0.121 | Alpha adrenoreceptor antagonist | 0.121 0.047 DBMET00836 | DBMET00836 | |
| 0.072 | 0.084 | 0.217 | Fibroblast growth factor 1 antagonist | 0.217 0.013 DBMET00836 | DBMET00836 | |
| 0.065 | 0.085 | 0.197 | Adrenaline antagonist | 0.197 0.024 DBMET00836 | DBMET00836 | |
| 0.044 | 0.079 | 0.098 | Alpha 1b adrenoreceptor antagonist | 0.098 0.036 DBMET00836 | DBMET00836 | |
| 0.024 | 0.063 | 0.153 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.153 0.005 DBMET00836 | DBMET00836 | |
| 0.03 | 0.075 | 0.136 | Poly(ADP-ribose) polymerase inhibitor | 0.136 0.005 DBMET00836 | DBMET00836 | |
| 0.044 | 0.093 | 0.175 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.175 0.01 DBMET00836 | DBMET00836 | |
| 0.06 | 0.13 | 0.101 | Granulocyte macrophage colony stimulating factor antagonist | 0.101 0.07 DBMET00836 | DBMET00836 | |
| 0.034 | 0.111 | 0.077 | Alpha 1 adrenoreceptor antagonist | 0.077 0.055 DBMET00836 | DBMET00836 | |
| 0.089 | 0.202 | 0.469 | Polo-like kinase-3 inhibitor | 0.469 0.004 DBMET00836 | DBMET00836 | |
| 0.03 | 0.191 | 0.077 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.077 0.076 DBMET00836 | DBMET00836 | |
| 0.024 | 0.185 | 0.063 | Phosphodiesterase V inhibitor | 0.063 0.06 DBMET00836 | DBMET00836 | |
| 0.023 | 0.197 | 0.063 | Phosphodiesterase 5A inhibitor | 0.063 0.058 DBMET00836 | DBMET00836 | |
| 0.022 | 0.339 | 0.134 | Abl kinase inhibitor | 0.134 0.057 DBMET00836 | DBMET00836 | |
| 0.022 | 0.34 | 0.134 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.134 0.057 DBMET00836 | DBMET00836 | |
| 0.019 | 0.387 | 0.122 | Protein kinase C delta inhibitor | 0.122 0.036 DBMET00836 | DBMET00836 | |
| 0.013 | 0.592 | 0.19 | Ephrin antagonist | 0.19 0.027 DBMET00836 | DBMET00836 | |
| 0.007 | 0.694 | 0.226 | Bronchodilator | 0.226 0.015 DBMET00836 | DBMET00836 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |